|

BI 3820768 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Boehringer Ingelheim1

Indications

  • Advanced Relapsed or Refractory Ovarian Cancer1
  • Advanced Relapsed or Refractory Endometrial Cancer1
  • Advanced Relapsed or Refractory Germ Cell Tumours1
  • Cancer1

Los Angeles, California1 trial

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Valkyrie Clinical Trials

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.